Indecomm: Todd Branning, Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc., a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced that it has appointed Todd Branning as chief financial officer. Interim CFO David Socks will continue with the company as a strategic adviser and remain a member of the board of directors.